RC, C., S, H., SR, L., L, K., J, M., Z, M., . . . MG, K. (2025). Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib. Nature communications, 16(1), 2242. https://doi.org/10.1038/s41467-025-57535-w
Chicago Style (17th ed.) CitationRC, Coombes, et al. "Author Correction: Dose Escalation and Expansion Cohorts in Patients with Advanced Breast Cancer in a Phase I Study of the CDK7-inhibitor Samuraciclib." Nature Communications 16, no. 1 (2025): 2242. https://doi.org/10.1038/s41467-025-57535-w.
MLA (9th ed.) CitationRC, Coombes, et al. "Author Correction: Dose Escalation and Expansion Cohorts in Patients with Advanced Breast Cancer in a Phase I Study of the CDK7-inhibitor Samuraciclib." Nature Communications, vol. 16, no. 1, 2025, p. 2242, https://doi.org/10.1038/s41467-025-57535-w.